Gentherm Incorporated (THRM) PT Lowered to $50 at Argus
Get Alerts THRM Hot Sheet
Rating Summary:
5 Buy, 5 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Argus analyst David Coleman lowered the price target on Gentherm Incorporated (NASDAQ: THRM) to $50.00 (from $55.00) while maintaining a Buy rating. The company's medical business rose 48.3% in 1Q, highlighting its ability to maneuver quickly in a rapidly changing environment. Although management withdrew its 2020 guidance due to the pandemic, Coleman believes that Gentherm is well positioned in key markets, which should drive revenue growth and margin expansion as the U.S. economy reopens.
THRM shares have outperformed over the last three months, rising 13.3% compared to an increase of 12.2% for the S&P500. Over the past year, the shares have risen 12.2% versus an increase of 12.0% for the index. The shares have under performed over the past five years, falling 21% compared to a gain of 53% for the index.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Home Depot (HD) PT Raised to $360 at Telsey, 'in the long term, Home Depot should remain a winner in retail'
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- Hyundai Mobis Co Ltd. (012330:KS) PT Raised to KRW340,000 at HSBC
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeRelated Entities
Standard & Poor's, ArgusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!